| Literature DB >> 23742214 |
Yusuke Kondo1, Marehiko Ueda, Michiko Watanabe, Masayuki Ishimura, Takatsugu Kajiyama, Naotaka Hashiguchi, Tomonori Kanaeda, Masahiro Nakano, Yasunori Hiranuma, Toru Ishizaka, Goro Matsumiya, Yoshio Kobayashi.
Abstract
BACKGROUND: Autonomic ganglionated plexi (GPs) play a significant role in the initiation and maintenance of atrial fibrillation (AF). GPs are key targets for a maze procedure. The purpose of this study was to identify the location of the left atrial GPs based on dense epicardial mapping during a maze procedure in patients with concomitant AF.Entities:
Keywords: atrial fibrillation; autonomic nervous system; ganglionated plexi; maze procedure
Mesh:
Year: 2013 PMID: 23742214 PMCID: PMC4285812 DOI: 10.1111/pace.12169
Source DB: PubMed Journal: Pacing Clin Electrophysiol ISSN: 0147-8389 Impact factor: 1.976
Figure 1New diagram of the epicardial mapping locations. Active GPs were predominantly identified in the anterior and inferior right region of the left atrium between the right PVs and the interatrial groove (pink circle). GPs = ganglionated plexi; LA = left atrium; LAA = left atrial appendage; LIPV = left inferior pulmonary vein; LSPV = left superior pulmonary vein; RIPV = right inferior pulmonary vein; RSPV = right superior pulmonary vein.
Figure 2Radiofrequency ganglionated plexi (GP) ablation in the left atrium with a dry bipolar pen probe. RIPV = right inferior pulmonary vein; RSPV = right superior pulmonary vein.
Figure 3Parasympathetic response elicited during a 4.85 second burst of high-frequency stimulation (HFS) applied to the ganglionated plexi (GP). (A) An atrioventricular block lasting 7.85 seconds was induced by HFS. The ventricular conduction quickly returned after the HFS was terminated. (B) The cardiac response to the GP stimulation was eliminated by radiofrequency ablation.
Clinical and Electrophysiological Characteristics of the Study Population
| Patient | Age | Sex | Active GPs on the Right Side | Active GPs on the Left Side | LAD | EF | Valve Operation | AF |
|---|---|---|---|---|---|---|---|---|
| 1 | 64 | F | 6,9,12 | None | 61 | 72 | MVP/TAP/CABG | Chronic |
| 2 | 16 | M | None | None | 50 | 59 | MVP/TAP | Chronic |
| 3 | 73 | F | 10 | None | 52 | 54 | AVR/TAP | Chronic |
| 4 | 73 | M | 6, 9,12 | None | 64 | 62 | MVP/TAP | Chronic |
| 5 | 69 | M | 10,12 | None | 43 | 57 | AVR/MV | Paroxysmal |
| 6 | 73 | F | 10 | 6 | 44 | 66 | MVP/TAP | Chronic |
| 7 | 73 | M | 7,10 | None | 62 | 49 | MVR/TAP/CABG | Chronic |
| 8 | 38 | M | 1,4,6,10 | None | 46 | 63 | MVP | Paroxysmal |
| 9 | 64 | M | I,4,7,10,12 | None | 40 | 67 | AVR | Paroxysmal |
| 10 | 78 | F | None | None | 54 | 34 | AVR/MVP | Chronic |
| 11 | 75 | M | 6,9 | 3 | 41 | 39 | AVR/TAP/CABG | Chronic |
| 12 | 48 | M | 1,3,6,7,10,11 | 1 | 50 | 38 | ASDC/TAP | Chronic |
| 13 | 73 | M | 9,12 | None | 58 | 60 | MVP/CABG | Chronic |
| 14 | 72 | F | None | None | 62 | 57 | MVP/TAP | Paroxysmal |
| 15 | 61 | M | 4,10,12 | 1 | 59 | 73 | MVP/CABG | Chronic |
| 16 | 64 | M | 3 | 9,10 | 56 | 65 | MVP | Chronic |
ASDC = atrial septal defect closure; AVR = aortic valve replacement; CABG = coronary artery bypass graft; EF = ejection fraction; F = female; LAD = left atrial diameter; M = male; MV = mitral valvuloplasty; MVR = mitral valve replacement; TAP = Tricuspid annuloplasty.
The Incidence of Activity according to the Epicardial Location
| Location | Right | Left |
|---|---|---|
| 1 | 3/16 (19%) | 2/16 (13%) |
| 2 | 0/16 (0%) | 0/16 (0%) |
| 3 | 2/16 (13%) | 1/16 (6%) |
| 4 | 3/16 (19%) | 0/16 (0%) |
| 5 | 0/16 (0%) | 0/16 (0%) |
| 6 | 1/16 (6%) | |
| 7 | 3/16 (19%) | 0/16 (0%) |
| 8 | 0/16 (0%) | 0/16 (0%) |
| 9 | 4/16 (25%) | 1/16 (6%) |
| 10 | 1/16 (6%) | |
| 11 | 1/16 (6%) | 0/16 (0%) |
| 12 | ||
| 13 | 0/16 (0%) |
Figure 4The fat pads on the right side of the left atrium.